A R T I C L E S
Oyler et al.
1H), 2.93 (t, J ) 5.04 Hz, 1H), 3.39 (m, 2H), 7.01 (s, 1H), 7.30 (m,
1H), 7.83 (t, J ) 7.78 Hz, 1H), 8.04 (s, 1H), 8.40 (d, J ) 7.93 Hz,
1H), 8.62 (s, 1H), 8.69 (d, J ) 3.97 Hz, 1H). 13C NMR (125 MHz,
CDCl3): δ 21.18, 26.61, 27.63, 40.22, 41.13, 41.15, 43.62, 48.26,
118.66, 121.33, 123.67, 128.23, 134.86, 137.16, 140.60, 148.00, 149.33,
154.04, 156.80, 156.96. [R]D -34° (25 °C, 5 mg in 5 mL of CHCl3).
[(7R,9R,10S)-pbpyCH2]3Ph(CH3)3 ((-)-L2). The ligand was pre-
pared via the procedure identical to that for (-)-L1, substituting 0.638
g (1.60 mmol) of tris(bromomethyl)mesitylene for 1,3,5-tris(bromo-
methyl)benzene and reacting with 4 (2.00 g, 8.00 mmol) and lith-
ium diisopropylamide (1.8 M in heptane/THF/ethylbenzene, 4.00 mL,
8.00 mmol) to yield 0.516 g (36%) after purification. 1H NMR
(500 MHz, CDCl3): δ 0.61 (s, 9H), 1.35 (s, 9H), 1.59 (d, J ) 9.77 Hz,
3H), 2.03 (m, 3H), 2.44 (s, 9H), 2.66 (m, 3H), 2.93 (t, J ) 5.34 Hz,
2.44 (m, 3H), 2.94 (m, 3H), 3.16 (m, 9H), 3.62 (t, J ) 8.25 Hz, 3H),
7.53 (s, 3H), 7.61 (m, 3H), 7.72 (d, J ) 4.27 Hz, 3H), 8.30 (t, J )
7.63 Hz, 3H), 8.38 (s, 3H), 8.66 (d, J ) 8.24 Hz, 3H). 13C NMR (125
MHz, d6-acetone): δ 17.54, 20.34, 25.59, 28.00, 35.75, 37.55, 42.16,
46.98, 48.78, 120.49, 123.32, 127.53, 135.18, 136.63, 136.88, 141.93,
146.93, 147.02, 147.94, 150.05, 162.37. MS (m/z; ESI): 1117 (2%,
M2+ - PF6-), 485 (100%, M2+ - 2PF6-). Anal. Calcd for C63H66N6-
Zn(PF6)2‚2H2O: C, 58.27; H, 5.43; N, 6.47. Found: C, 58.48; H, 5.17;
N, 6.39.
Λ-Hemicage Complexes. The (+)-L1 and (+)-L2 ligands were
synthesized starting from (1S,5R)-(-)-nopinone and otherwise prepared
in a fashion similar to the procedures described above. Λ-Ru(II)
complexes were prepared from both (+)-L1 and (+)-L2, while a Λ-Zn-
(II) complex was prepared from (+)-L2.
9H), 3.15 (m, 3H), 3.30 (d, J ) 10.99 Hz, 3H), 3.39 (dd, J1
)
Racemic Hemicages. [bpy(CH2)2]3Ph(CH3)3 (L3). 5-Methyl-2,2′-
bipyridine (4.14 g, 0.0245 mol) was dissolved with stirring in 100 mL
of anhydrous THF at -78 °C under N2. Lithium diisopropylamide (2.0
M in heptane/THF/ethylbenzene, 12.25 mL, 0.0245 mol) was added
dropwise by syringe over 30 min; the resulting black solution was then
stirred for an additional 15 min. Tris(bromomethyl)mesitylene (1.95
g, 0.00490 mol) was dissolved in 50 mL of anhydrous THF and added
dropwise by syringe over 3 h. After being stirred for an additional hour,
the black solution was poured into 500 mL of hexanes, forming a cloudy
blue mixture that gradually turned yellow. After being filtered, the
yellow solid was washed with hexanes and then dissolved in 500 mL
of CH2Cl2. The solution was washed with 10% NH4Cl solution and
backwashed with water, and then the combined organic layers were
dried over Na2SO4 (s) and concentrated to dryness by rotary evaporation
to yield 2.90 g (89%) of yellow, solid product of sufficient purity to
carry out metal complexation reactions. For characterization experi-
ments, the ligand was further purified by recrystallization from hexanes/
4.12 Hz, J2 ) 14.19), 7.31 (m, 3H), 7.82 (t, J ) 7.63 Hz, 3H), 8.06
(s, 3H), 8.41 (d, J ) 7.63 Hz, 3H), 8.65 (s, 3H), 8.68 (m, 3H). 13C
NMR (125 MHz, CDCl3): δ 21.01, 26.61, 29.03, 34.76, 41.08, 41.14,
43.82, 48.27, 118.69, 121.40, 123.74, 134.18, 135.08, 135.85, 137.21,
147.65, 147.78, 149.32, 156.45, 156.66. [R]D -183° (25 °C, 5 mg in
5 mL CHCl3).
∆-[Ru((-)-L1)](PF6)2 (7). (-)-L1 (0.100 g, 0.116 mmol) was
dissolved in 100 mL of hot ethanol, and Ru(DMSO)4Cl2 (0.056 g, 0.116
mmol) was added in small portions over 30 min. The red solution was
heated under reflux for 3 h before removal of the solvent by rotary
evaporation. The resulting red solid was then dissolved in 50 mL of
water, and a solution of ammonium hexafluorophosphate (1.00 g) in 5
-
mL of water was added to precipitate the ruthenium complex as a PF6
salt. The complex was separated by filtration, dissolved in acetone,
and filtered through a short column of aluminum oxide to remove
polymeric impurities. Following evaporation of the solvent from the
filtrate, recrystallization by vapor diffusion of acetonitrile and ether
yielded 0.030 g (21%) of pure product. 1H NMR (500 MHz, d6-
acetone): δ 0.36 (s, 9H), 1.48 (s, 9H), 1.86 (d, J ) 10.38 Hz, 3H),
2.40 (m, 3H), 2.87 (m, 6H), 3.12 (t, J ) 5.49 Hz, 3H), 3.29 (m, 3H),
3.67 (m, 3H), 7.36 (s, 3H), 7.41 (d, J ) 5.19 Hz, 3H), 7.47 (m, 1H),
7.76 (s, 3H), 8.13 (t, J ) 7.64 Hz, 3H), 8.40 (s, 3H), 8.69 (d, J ) 8.24
Hz, 3H). 13C NMR (125 MHz, d6-acetone): δ 20.30, 25.55, 28.22,
39.23, 41.47, 41.85, 47.01, 48.50, 121.05, 124.16, 127.31, 130.91,
137.62, 138.06, 140.63, 150.09, 151.00, 154.51, 157.87, 158.34. MS
(m/z; ESI): 1111 (1%, M2+ - PF6-), 483 (100%, M2+ - 2PF6-). Anal.
Calcd for C60H60N6Ru(PF6)2‚2H2O: C, 55.77; H, 4.99; N, 6.50.
Found: C, 55.97; H, 5.00; N, 6.13.
1
dichloromethane. H NMR (400 MHz, CDCl3): δ 2.37 (s, 9H), 2.84
(m, 6H), 3.05 (m, 6H), 7.30 (m, 3H), 7.68 (dd, J1 ) 8.13 Hz, J2 )
2.24 Hz, 3H), 7.82 (td, J1 ) 7.55 Hz, J2 ) 1.81 Hz, 3H), 8.37 (m, 6H),
8.56 (s, 3H), 8.69 (m, 3H). 13C NMR (125 MHz, CDCl3): δ 16.25,
32.73, 33.00, 121.15, 123.82, 132.59, 136.39, 137.10, 137.27, 137.81,
149.33, 149.37, 154.29, 156.26.
∆/Λ-[Ru(L3)](PF6)2 (11). The complex was prepared via a procedure
identical to that for 7. L3 (0.100 g, 0.149 mmol) and Ru(DMSO)4Cl2
(0.072 g, 0.149 mmol) were combined to give 0.035 g (22%) of product.
1H NMR (500 MHz, d6-acetone): δ 1.96 (s, 9H), 2.77 (m, 3H), 2.92
(m, 3H), 3.07 (m, 3H), 3.31 (m, 3H), 6.49 (d, J ) 1.46 Hz, 3H), 7.51
(td, J1 ) 6.23 Hz, J2 ) 1.46 Hz, 3H), 8.06 (d, J ) 5.49 Hz, 3H), 8.12
(td, J1 ) 7.69 Hz, J2 ) 1.46 Hz, 3H), 8.28 (dd, J1 ) 8.42 Hz, J2 )
1.83 Hz, 3H), 8.65 (t, J ) 8.06 Hz, 6H). 13C NMR (125 MHz, d6-
acetone): δ 16.92, 29.50, 30.89, 124.29, 127.74, 134.06, 134.85, 138.01,
138.55, 141.08, 151.74, 151.88, 154.96, 157.30. MS (m/z; ESI): 913
(5%, M2+ - PF6-), 384 (100%, M2+ - 2PF6-). Anal. Calcd for
C45H42N6Ru(PF6)2‚2H2O: C, 49.41; H, 4.24; N, 7.68. Found: C, 49.68;
H, 4.16; N, 7.68.
∆-[Ru((-)-L2)](PF6)2 (8). The procedure identical to that for 7 was
used, substituting 0.100 g (0.110 mmol) of ligand (-)-L2 in place of
(-)-L1. Complexation with Ru(DMSO)4Cl2 (0.053 g, 0.110 mmol) and
recrystallization yielded 0.039 g (27%). 1H NMR (500 MHz, d6-
acetone): δ 0.34 (s, 9H), 1.49 (s, 9H), 2.02 (d, J ) 10.38 Hz, 3H),
2.23 (s, 9H), 2.45 (m, 3H), 2.97 (m, 3H), 3.15 (m, 9H), 3.62 (t, J )
8.24 Hz, 3H), 7.35 (s, 3H), 7.47 (m, 3H), 7.50 (d, J ) 4.58 Hz, 3H),
8.13 (t, J ) 7.63 Hz, 3H), 8.40 (s, 3H), 8.67 (d, J ) 8.24 Hz, 3H). 13
C
∆/Λ-[Zn(L3)](PF6)2 (12). The complex was prepared by dissolving
L3 (0.100 g, 0.150 mmol) in hot ethanol (200 mL) followed by the
addition of NH4PF6 (0.200 g) and ZnCl2 (0.020 g, 0.130 mmol). After
being refluxed overnight, 100 mL of solution was removed by rotary
evaporation, leading to the precipitation of white product. Subsequent
filtering and recrystallization via vapor diffusion of acetonitrile/ether
NMR (125 MHz, d6-acetone): δ 17.66, 20.29, 25.60, 28.08, 35.81,
37.53, 42.46, 46.93, 48.45, 121.17, 124.13, 127.35, 135.05, 136.60,
137.51, 137.61, 149.66, 151.10, 151.10, 154.56, 158.04, 158.13. MS
(m/z; ESI): 1155 (4%, M2+ - PF6-), 504 (100%, M2+ - 2PF6-). Anal.
Calcd for C63H66N6Ru(PF6)2‚2H2O: C, 56.71; H, 5.29; N, 6.30.
Found: C, 56.69; H, 5.27; N, 6.09.
1
gave 0.090 g (58%) of the pure metal complex. H NMR (400 MHz,
∆-[Zn((-)-L2)](PF6)2 (9). The complex was prepared by dissolving
(-)-L2 (0.050 g, 0.058 mmol) in hot ethanol (100 mL) along with ZnCl2
(0.008 g, 0.058 mmol) and refluxing for 4 h. The solvent was removed
by rotary evaporation, and the resulting white solid was dissolved in
50 mL of water and then treated with 1.00 g of NH4PF6 (dissolved in
5 mL of water) to precipitate the complex. Subsequent filtering and
recrystallization via vapor diffusion of acetonitrile/ether gave 0.040 g
d6-acetone): δ 2.08 (s, 9H), 2.90 (m, 3H), 3.00 (m, 3H), 3.15 (m, 3H),
3.38 (m, 3H), 6.63 (s, 3H), 7.73 (t, J ) 1.10 Hz, 3H), 8.37 (t, J ) 7.87
Hz, 3H), 8.41 (d, J ) 4.76 Hz, 3H), 8.52 (d, 8.06 Hz, 3H), 8.76 (d,
J ) 8.05 Hz, 6H). 13C NMR (125 MHz, d6-acetone): δ 16.90, 29.50,
30.82, 123.26, 123.58, 127.59, 134.08, 134.89, 141.00, 142.06, 142.61,
147.06, 148.39, 148.64, 149.57. MS (m/z; ESI): 876 (17%, M2+
-
PF6-), 365 (100%, M2+ - 2PF6-). Anal. Calcd for C45H42N6Zn(PF6)2‚
1.5H2O: C, 51.51; H, 4.32; N, 8.01. Found: C, 51.42; H, 3.96;
N, 7.82.
1
(57%) of pure metal complex. H NMR (500 MHz, d6-acetone): δ
0.34 (s, 9H), 1.47 (s, 9H), 1.91 (d, J ) 10.38 Hz, 3H), 2.25 (s, 9H),
9
212 J. AM. CHEM. SOC. VOL. 129, NO. 1, 2007